Fernando Campos, Deputy Chair – Sarcoma and Bone Tumors Reference Center at A.C. Camargo Cancer Center, shared on LinkedIn:
“My first editorial, and an incredible privilege to share this milestone with one of the world’s leading desmoid tumor experts: Bernd Kasper.
In this work, we explore how gamma-secretase inhibitors are reshaping desmoid tumor care, while thoughtfully considering their role among other treatment approaches, including active surveillance.”
Title: How have gamma-secretase inhibitors changed the treatment landscape for desmoid tumors?
Authors: Fernando Campos, Bernd Kasper
Read The Full Article
Other articles about Gamma-Secretase Inhibitors on OncoDaily.
